SUBSCRIBE
SUBSCRIBE
News   Drug Development

Active Biotech AB’s I-3D Micro-dosing Clinical Trial Concluded

March 13, 2007 | 
1 min read
LUND, SWEDEN -- (MARKET WIRE) -- March 13, 2007 -- Active Biotech AB (Stockholm:ACTI.ST) and Chelsea Therapeutics International Ltd (NASDAQ: CHTP) has performed a first human micro-dosing trial of an I-3D compound.
Clinical research Phase I Europe
MORE ON THIS TOPIC
Abstract creative art collage, market declines in the stock market. The concept of collapse or bankruptcy.
Weight loss
Viking Crashes as Obesity Pill Delivers Over 12% Weight Loss
August 19, 2025
 · 
2 min read
 · 
Tristan Manalac
Hands in black and white dropping a collection of pills on a pink background
Manufacturing
Oral Wegovy’s Pending Approval Puts Spotlight on Viability of High-Dose Peptides
August 19, 2025
 · 
5 min read
 · 
Nick Paul Taylor
Poster sketch image artwork photo collage of body language finger showing gesture symbol thumb down dislike dissatisfied minus no opinion.
Sickle cell disease
Pfizer’s $5.4B GBT Bet Disappoints Again as Sickle Cell Therapy Fails in Phase III
August 18, 2025
 · 
2 min read
 · 
Tristan Manalac
US Dollar coin and EU currencies on weighing scale against Unated States and European Union flags as symbol of trade war, economic conflict. Selective focus on Dollar.
Drug pricing
Lilly Aims To Raise Europe Drug Prices in Response to Trumps’ Most Favored Nation Policy
August 14, 2025
 · 
3 min read
 · 
Annalee Armstrong